As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, “Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence,” explores how GCCs—especially those based in India—are reshaping how the industry manages scientific content and scales global operations.
This resource offers a deep dive into why some organizations choose to build in-house GCCs while others benefit from partnering with specialized medical communications agencies. With real-world case studies, data-backed insights, and strategic frameworks, the whitepaper makes a compelling case for adopting a hybrid approach that blends scientific rigor with technology-driven delivery models.
Download this whitepaper to learn more about
- How GCCs have evolved from transactional support hubs to strategic centers driving innovation, standardization, and scientific excellence
- Why India is the preferred destination for life sciences GCCs—thanks to its skilled talent pool, digital infrastructure, and cost advantage
- What differentiates specialized medical communications agencies with scientific expertise from traditional outsourcing firms and tech consultancies in building high-performing GCCs
- How global biopharma leaders like Merck and GSK are successfully using GCCs to manage content, streamline operations, and scale scientific communications
- What it takes to build or enhance a GCC that aligns with your global content strategy, regulatory needs, and future growth ambitions
Laura Perry
Vice President of Marketing
Kwisha Shah
Marketing Content Manager